Analyst Ranking
Top 26%
#1299 out of 4937 analysts
Average Return
+1.79%
Win Rate
50%57 out of 115
Risk vs Reward
Poor
Good

David Lebovitz's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Clementia Pharmaceuticals IncCMTA
+202.87%$8.70$26.35
2018-08-12 -
2019-04-17
Strong Buy
Avexis IncAVXS
+129.75%$94.81$217.83
2017-08-02 -
2018-05-15
Strong Buy
Avexis IncAVXS
+124.59%$96.99$217.83
2017-11-12 -
2018-05-15
Strong Buy
Ascendis Pharma AASND
+107.40%$71.19$147.65
2023-04-04 -
2024-04-04
Strong Buy
Bridgebio Pharma IncBBIO
+77.50%$26.18$46.47
2024-08-01 -
2025-07-11
Strong Buy

David Lebovitz's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bridgebio Pharma IncBBIO
5Strong Buy$67.00+44.18%Maintains
3 days ago
Ascendis Pharma AASND
12Strong Buy$243.00+38.89%Maintains
3 days ago
Alnylam Pharmaceuticals IncALNY
24Strong Buy$404.00+28.28%Maintains
3 days ago
Blueprint Medicines CorpBPMC
8Hold$129.00-0.23%Upgrades
a month ago
Exelixis IncEXEL
3Strong Buy$56.00+24.83%Maintains
2 months ago
Intellia Therapeutics IncNTLA
8Hold$10.00-13.31%Maintains
2 months ago
Cytokinetics IncCYTK
2Strong Buy$80.00+116.16%Maintains
2 months ago
Biomarin Pharmaceutical IncBMRN
7Hold$78.00+34.25%Maintains
2 months ago
Pliant Therapeutics IncPLRX
6Hold$1.50+6.38%Maintains
4 months ago
Madrigal Pharmaceuticals IncMDGL
5Strong Buy$469.00+48.67%Maintains
5 months ago
Ionis Pharmaceuticals IncIONS
10Strong Buy$64.00+53.37%Maintains
5 months ago
Ptc Therapeutics IncPTCT
9Strong Sell$45.00-7.31%Maintains
5 months ago
Incyte CorpINCY
5Strong Buy$88.00+28.30%Maintains
5 months ago
Viking Therapeutics IncVKTX
1Hold$38.00+22.15%Initiates Coverage On
5 months ago
Crinetics Pharmaceuticals IncCRNX
2Strong Buy$74.00+131.76%Maintains
8 months ago
Mirum Pharmaceuticals IncMIRM
5Strong Buy$68.00+29.13%Maintains
8 months ago
Celldex Therapeutics IncCLDX
1Strong Buy$70.00+205.54%Initiates Coverage On
9 months ago
Cogent Biosciences IncCOGT
3Strong Buy$15.00+36.61%Maintains
10 months ago
Schrodinger IncSDGR
7Strong Buy$37.00N/AMaintains
a year ago
Immuneering CorpIMRX
2Hold$12.00N/AMaintains
3 years ago
Arcutis Biotherapeutics IncARQT
5Strong Buy$36.00N/AMaintains
3 years ago
Syndax Pharmaceuticals IncSNDX
1Hold$21.00N/AMaintains
4 years ago
Karyopharm Therapeutics IncKPTI
3Strong Buy$405.00N/AMaintains
4 years ago
Ironwood Pharmaceuticals IncIRWD
5Hold$14.00N/AMaintains
4 years ago
Tectonic Therapeutic IncTECX
7Strong Buy$300.00N/AMaintains
4 years ago
Epizyme IncEPZM
2Strong Sell$5.00N/ADowngrades
4 years ago
Rhythm Pharmaceuticals IncRYTM
2Strong Buy$57.00N/AMaintains
4 years ago
Macrogenics IncMGNX
1Strong Sell$15.00N/AMaintains
4 years ago
Gw Pharmaceuticals PLCGWPH
1Hold$220.00N/ADowngrades
4 years ago
Nabriva Therapeutics PLCNBRVF
2Hold$500.00N/AMaintains
5 years ago
Zealand Pharma AZEAL
1Strong Buy$37.00N/AMaintains
5 years ago
Clementia Pharmaceuticals IncCMTA
2Strong Buy$26.00N/AMaintains
7 years ago
Avexis IncAVXS
3Strong Buy$129.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.